A weekly winners-and-losers list tells you how far a share moved. Does it tell you why? Iggy and Angela use one hotel owner’s rise and one palm oil producer’s fall to ask three questions: what the list covers, what reason the source gives, and what a single week can tell a long-term shareholder.
A weekly list said one hotel and property owner rose 11.9%, while a palm oil producer fell 13.6%. Angela’s husband wondered whether haze caused the fall, but the list gave no reason. I explain three questions to ask before connecting a price move to a headline, including what the list leaves out, what the source actually says, and what one week cannot tell a long-term shareholder.
Key takeaways:
The list covers only shares above one billion dollars and shows five gainers and five losers over five trading days.
A 13.6% fall needs a 15.7% rise to return to its starting price.
The source links palm oil shares to scrutiny over haze-causing fires, but does not say that caused this producer’s fall.
A company’s own exchange announcements, not a weekly list, are where a price-move reason should be checked.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor. I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered.
Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle. Stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst. These carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors.
All data is sourced from public filings and verified sources. Where data is unverified, it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
